# The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

> **NCT02403284** · PHASE4 · COMPLETED · sponsor: **Phoenix VA Health Care System** · enrollment: 97 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Sugar Pill

## Key facts

- **NCT ID:** NCT02403284
- **Lead sponsor:** Phoenix VA Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2021-04-28
- **Final completion:** 2023-11-01
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2024-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02403284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02403284, "The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02403284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*